Treatment of Mycobacterium avium in human immunodeficiency virus- Infected individuals

American Journal of Medicine

Volumn 102, Issue 5 C, 1997, Pages 16-21

  Koletar, Susan L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL; GENTAMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; SPARFLOXACIN;

ARTICLE; COLONY FORMING UNIT; DRUG EFFICACY; DRUG HALF LIFE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0030806836     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(97)00039-9     Document Type: Article

References (34)

1. Greene JB, Sidhu GS, Lewin S, et al. Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med. 97:1982;539-546.
2. Zakowski P, Fligiel S, Berlin OGW, Johnson BL Jr. Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency. JAMA. 248:1982;2980-2982.
3. Wong B, Edwards FF, Kiehn TE, et al. Continuous high-grade Mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med. 78:1985;35-40.
4. Hawkins CC, Gold JWM, Whimbey E, et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 105:1986;184-188.
5. Masur H, Tuazon C, Gill V, et al. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. J Infect Dis. 155:1987;127-129.
6. Agins BD, Berman DS, Spiecehandler D, el-Sadr W, Simberkoff MS, Rahal JJ. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis. 159:1989;784-787.
7. Hoy J, Mijch A, Sandland M, Grayson L, Lucas R, Dwyer B. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis. 161:1990;801-805.
8. Chiu J, Nussbaum J, Bozzette S, et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. Ann Intern Med. 113:1990;358-361.
9. Benson CA, Kessler HA, Pottage JC, Trenholme GM. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Arch Intern Med. 151:1991;582-585.
10. Kemper CA, Meng TC, Nussbaum J, et al. Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. Ann Intern Med. 116:1992;466-472.
11. Jacobson MA, Yajko D, Northfelt D, et al. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. J Infect Dis. 168:1993;112-119.
12. Horsburgh CR Jr, Havlik JA, Ellis DA, et al. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis. 144:1991;557-559.
13. Kerlikowske KM, Katz MH, Chan AK, Perez-Stable EJ. Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. Arch Intern Med. 152:1992;813-817.
14. Chin DP, Reingold AL, Stone EN, et al. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients - a prospective study. J Infect Dis. 170:1994;578-584.
15. Kemper CA, Havlir D, Haghighat D, et al. The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis. 170:1994;157-164.
16. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med. 329:1993;828-833.
17. Sullam PM, Gordin FM, Wynne BA. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. Clin Inf Dis. 19:1994;84-86.
18. Dautzenberg B, Castellani P, Pellegrin JL, et al. Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients. Antimicrob Agents Chemother. 40:1996;1722-1725.
19. Bermudez LE, Yau-Young AO, Lin JP, Cogger J, Young LS. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. J Infect Dis. 161:1990;1262-1268.
20. Nightingale SD, Saletan SL, Swenson CE, et al. Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob Agents Chemother. 37:1993;1869-1872.
21. Young LS, Wu M, Bender J, for the Sparfloxacin Study Group. Pilot study of sparfloxacin for M. avium complex (MAC) bacteremia complicating AIDS. (Abstr. 897.) 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, 1992.
22. Dautzenberg B, Truffot C, Legris S, et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. Am Rev Respir Dis. 144:1991;564-569.
23. Dautzenberg B, Saint Marc T, Meyohas M-C, et al. Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. Arch Intern Med. 153:1993;368-372.
24. Chaisson RE, Benson CA, Dube MP, et al. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind dose-ranging study in patients with AIDS. Ann Intern Med. 121:1994;905-911.
25. Inderlied CB, Kolonoski PT, Wu M, Young LS. In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex. J Infect Dis. 159:1989;994-997.
26. Girard AE, Girard D, English AR, et al. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother. 31:1987;1948-1954.
27. Young LS, Wiviott L, Wu M, Kolonoski P, Bolan R, Inderlied CB. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet. 338:1991;1107-1109.
28. Berry AJ, Koletar S, Williams D. Azithromycin for disseminated Mycobacterium avium-intracellulare in AIDS patients. (Abstr. 292.) 1st National Conference on Human Retroviruses and Related Infections, Washington, DC, 1993.
29. Bermudez LE, Petrofsky M, Kolonoski P, Young LS. Emergence of Mycobacterium avium (MAC) populations resistant to macrolides during experimental chemotherapy. (Abstr. C145.) 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996.
30. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med. 335:1996;377-383.
31. Dube M, Sattler F, Torriani F, et al. Prevention of relapse of MAC bacteremia in AIDS: a randomized study of clarithromycin plus clofazimine, with or without ethambutol. (Abstr. 206.) 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996.
32. Chaisson RE, Keiser P, Pierce M, et al. Controlled trial of clarithromycin/ethambutol with or without clofazimine for Mycobacterium avium complex bacteremia in AIDS. (Late Breaker Abstract Book.) 3rd Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996.
33. May T, Brel F, Beuscart C, et al. A French randomized open trial of combination therapy for MAC bacteremia. (Abstr. I202.) 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995.
34. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. N Engl J Med. 329:1993;898-904.